Abstract
The in vitro micronucleus assay is broadly used, but is not per se able to discriminate aneugenic from clastogenic compounds, and cytotoxicity can be a confounding factor. In vitro genotoxicity assays generally rely on cell lines with limited metabolic capabilities. Recently, the use of histone H2AX and H3 phosphorylation markers (γH2AX and p-H3) was proposed to discriminate aneugenic from clastogenic chemicals. The aim of the present study was to develop a new genotoxic screening strategy based on the use of the γH2AX and p-H3 biomarkers in combination with cell lines with distinct biotransformation properties. First, we tested a training set of 20 model chemicals comprised of 10 aneugens, five clastogens and five cytotoxics on three human cell lines (HepG2, LS-174T and ACHN). Our data confirm the robustness of these two biomarkers to discriminate efficiently clastogens, aneugens and misleading cytotoxic chemicals in HepG2 cells. Aneugenic compounds induced either an increase or a decrease in p-H3 depending on their mode of action. Clastogens induced γH2AX, and cytotoxic compounds generated a marked decrease in these two biomarkers. Moreover, the use of different cell lines permits to discriminate direct from bioactivated genotoxins without the need of an exogenous metabolic activation system. Finally, we further evaluated this strategy using a test set of 13 chemicals with controversial genotoxic potential. The resulting data demonstrate that the combined analysis of γH2AX and p-H3 is an efficient strategy. Notably, we demonstrated that three compounds (fisetin, hydroquinone and okadaic acid) display both aneugenic and clastogenic properties.
Similar content being viewed by others
References
Ando M, Yoshikawa K, Iwase Y, Ishiura S (2014) Usefulness of monitoring gamma-H2AX and cell cycle arrest in HepG2 cells for estimating genotoxicity using a high-content analysis system. J Biomol Screen 19:1246–1254
Antoccia A, Degrassi F, Battistoni A, Ciliutti P, Tanzarella C (1991) In vitro micronucleus test with kinetochore staining: evaluation of test performance. Mutagenesis 6:319–324
Attia SM (2009) Use of centromeric and telomeric DNA probes in in situ hybridization for differentiation of micronuclei induced by lomefloxacin. Environ Mol Mutagen 50:394–403
Attia SM, Ashour AE, Bakheet SA (2013) Comet-FISH studies for evaluation of genetic damage of citalopram in somatic cells of the mouse. J Appl Toxicol 33:901–905
Audebert M, Riu A, Jacques C, Hillenweck A, Jamin EL, Zalko D, Cravedi JP (2010) Use of the gammaH2AX assay for assessing the genotoxicity of polycyclic aromatic hydrocarbons in human cell lines. Toxicol Lett 199:182–192
Audebert M, Dolo L, Perdu E, Cravedi JP, Zalko D (2011) Use of the gammaH2AX assay for assessing the genotoxicity of bisphenol A and bisphenol F in human cell lines. Arch Toxicol 85:1463–1473
Audebert M, Zeman F, Beaudoin R, Pery A, Cravedi JP (2012) Comparative potency approach based on H2AX assay for estimating the genotoxicity of polycyclic aromatic hydrocarbons. Toxicol Appl Pharmacol 260:58–64
Banerjee T, Chakravarti D (2011) A peek into the complex realm of histone phosphorylation. Mol Cell Biol 31:4858–4873
Bellincampi D, Gualandi G, la Monica E, Poley C, Morpurgo GP (1980) Membrane-damaging agents cause mitotic non-disjunction in Aspergillus nidulans. Mutat Res 79:169–172
Brambilla G, Martelli A (2009) Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals. Mutat Res 681:209–229
Brambilla G, Mattioli F, Martelli A (2009) Genotoxic and carcinogenic effects of antipsychotics and antidepressants. Toxicology 261:77–88
Brunner M, Albertini S, Wurgler FE (1991) Effects of 10 known or suspected spindle poisons in the in vitro porcine brain tubulin assembly assay. Mutagenesis 6:65–70
Bryce SM, Bemis JC, Mereness JA, Spellman RA, Moss J, Dickinson D, Schuler MJ, Dertinger SD (2014) Interpreting in vitro micronucleus positive results: simple biomarker matrix discriminates clastogens, aneugens, and misleading positive agents. Environ Mol Mutagen 55:542–555
Cheung JR, Dickinson DA, Moss J, Schuler MJ, Spellman RA, Heard PL (2015) Histone markers identify the mode of action for compounds positive in the TK6 micronucleus assay. Mutat Res Genet Toxicol Environ Mutagen 777:7–16
Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, Pan Y, Nezi L, Protopopov A, Chowdhury D, Pellman D (2012) DNA breaks and chromosome pulverization from errors in mitosis. Nature 482:53–58
Di Virgilio AL, Iwami K, Watjen W, Kahl R, Degen GH (2004) Genotoxicity of the isoflavones genistein, daidzein and equol in V79 cells. Toxicol Lett 151:151–162
Dorn SB, Degen GH, Muller T, Bonacker D, Joosten HF, van der Louw J, van Acker FA, Bolt HM (2007) Proposed criteria for specific and non-specific chromosomal genotoxicity based on hydrophobic interactions. Mutat Res 628:67–75
EFSA (2007) Conclusion regarding the peer review of the pesticide risk assessment of the active substance fludioxonil. http://www.efsa.europa.eu/en/efsajournal/doc/praper_concl_sr110_fludioxonil_en.pdf?ssbinary=true
Elhajouji A, Tibaldi F, Kirsch-Volders M (1997) Indication for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in vitro in human lymphocytes. Mutagenesis 12:133–140
Eriksen KT, Raaschou-Nielsen O, Sorensen M, Roursgaard M, Loft S, Moller P (2010) Genotoxic potential of the perfluorinated chemicals PFOA, PFOS, PFBS, PFNA and PFHxA in human HepG2 cells. Mutat Res 700:39–43
Fessard V, Grosse Y, Pfohl-Leszkowicz A, Puiseux-Dao S (1996) Okadaic acid treatment induces DNA adduct formation in BHK21 C13 fibroblasts and HESV keratinocytes. Mutat Res 361:133–141
Florentin A, Deblonde T, Diguio N, Hautemaniere A, Hartemann P (2011) Impacts of two perfluorinated compounds (PFOS and PFOA) on human hepatoma cells: Cytotoxicity but no genotoxicity? Int J Hyg Environ Health 214:493–499
Fowler P, Smith K, Young J, Jeffrey L, Kirkland D, Pfuhler S, Carmichael P (2012) Reduction of misleading (“false”) positive results in mammalian cell genotoxicity assays. I. Choice of cell type. Mutat Res 742:11–25
Garcia-Canton C, Anadon A, Meredith C (2013a) Assessment of the in vitro gammaH2AX assay by high content screening as a novel genotoxicity test. Mutat Res 757:158–166
Garcia-Canton C, Anadon A, Meredith C (2013b) Genotoxicity evaluation of individual cigarette smoke toxicants using the in vitro gammaH2AX assay by high content screening. Toxicol Lett 223:81–87
Gollapudi P, Hasegawa LS, Eastmond DA (2014) A comparative study of the aneugenic and polyploidy-inducing effects of fisetin and two model Aurora kinase inhibitors. Mutat Res, Genet Toxicol Environ Mutagen 767:37–43
Graillot V, Takakura N, Hegarat LL, Fessard V, Audebert M, Cravedi JP (2012a) Genotoxicity of pesticide mixtures present in the diet of the French population. Environ Mol Mutagen 53:173–184
Graillot V, Tomasetig F, Cravedi JP, Audebert M (2012b) Evidence of the in vitro genotoxicity of methyl-pyrazole pesticides in human cells. Mutat Res 748:8–16
Guo L, Dial S, Shi L, Branham W, Liu J, Fang JL, Green B, Deng H, Kaput J, Ning B (2011) Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes. Drug Metab Dispos 39:528–538
Hans F, Dimitrov S (2001) Histone H3 phosphorylation and cell division. Oncogene 20:3021–3027
Harrington EA, Bebbington D, Moore J, Rasmussen RK, Ajose-Adeogun AO, Nakayama T, Graham JA, Demur C, Hercend T, Diu-Hercend A, Su M, Golec JM, Miller KM (2004) VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med 10:262–267
Hashimoto K, Nakajima Y, Matsumura S, Chatani F (2010) An in vitro micronucleus assay with size-classified micronucleus counting to discriminate aneugens from clastogens. Toxicol In Vitro 24:208–216
Heard PL, Rubitski EE, Spellman RA, Schuler MJ (2013) Phenolphthalein induces centrosome amplification and tubulin depolymerization in vitro. Environ Mol Mutagen 54:308–316
Hernandez LG, van Benthem J, Johnson GE (2013) A mode-of-action approach for the identification of genotoxic carcinogens. PLoS ONE 8:e64532
Jacquet N, Maire MA, Landkocz Y, Vasseur P (2012) Carcinogenic potency of perfluorooctane sulfonate (PFOS) on Syrian hamster embryo (SHE) cells. Arch Toxicol 86:305–314
Janssen A, van der Burg M, Szuhai K, Kops GJ, Medema RH (2011) Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 333:1895–1898
Kersten B, Zhang J, Brendler-Schwaab SY, Kasper P, Muller L (1999) The application of the micronucleus test in Chinese hamster V79 cells to detect drug-induced photogenotoxicity. Mutat Res 445:55–71
Khoury L, Zalko D, Audebert M (2013) Validation of high-throughput genotoxicity assay screening using gammaH2AX in-cell western assay on HepG2 cells. Environ Mol Mutagen 54:737–746
Khoury L, Zalko D, Audebert M (2015) Evaluation of four human cell lines with distinct biotransformation properties for genotoxic screening. Mutagenesis. doi:10.1093/mutage/gev058
Kirkland D (2011) Improvements in the reliability of in vitro genotoxicity testing. Expert Opin Drug Metab Toxicol 7:1513–1520
Kirkland D, Kasper P, Muller L, Corvi R, Speit G (2008) Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: a follow-up to an ECVAM workshop. Mutat Res 653:99–108
Kligerman AD, Young RR, Stankowski LF, Jr, Pant K, Lawlor T, Aardema MJ, Houck KA (2015) An evaluation of 25 selected ToxCast chemicals in medium-throughput assays to detect genotoxicity. Environ Mol Mutagen 2014 Dec 23. doi:10.1002/em.21934
Ku WW, Bigger A, Brambilla G, Glatt H, Gocke E, Guzzie PJ, Hakura A, Honma M, Martus HJ, Obach RS, Roberts S (2007) Strategy for genotoxicity testing–metabolic considerations. Mutat Res 627:59–77
Kuehner S, Holzmann K, Speit G (2013) Characterization of formaldehyde’s genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol 87:1999–2012
Kumari A, Lim YX, Newell AH, Olson SB, McCullough AK (2012) Formaldehyde-induced genome instability is suppressed by an XPF-dependent pathway. DNA Repair (Amst) 11:236–246
Kurebayashi H, Okudaira K, Ohno Y (2010) Species difference of metabolic clearance of bisphenol A using cryopreserved hepatocytes from rats, monkeys and humans. Toxicol Lett 198:210–215
Le Hegarat L, Puech L, Fessard V, Poul JM, Dragacci S (2003) Aneugenic potential of okadaic acid revealed by the micronucleus assay combined with the FISH technique in CHO-K1 cells. Mutagenesis 18:293–298
Lin J, Schyschka L, Muhl-Benninghaus R, Neumann J, Hao L, Nussler N, Dooley S, Liu L, Stockle U, Nussler AK, Ehnert S (2012) Comparative analysis of phase I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism. Arch Toxicol 86:87–95
Lu K, Collins LB, Ru H, Bermudez E, Swenberg JA (2010) Distribution of DNA adducts caused by inhaled formaldehyde is consistent with induction of nasal carcinoma but not leukemia. Toxicol Sci 116:441–451
Matsuzaki K, Harada A, Takeiri A, Tanaka K, Mishima M (2010) Whole cell-ELISA to measure the gammaH2AX response of six aneugens and eight DNA-damaging chemicals. Mutat Res 700:71–79
Mazur CS, Kenneke JF, Hess-Wilson JK, Lipscomb JC (2010) Differences between human and rat intestinal and hepatic bisphenol-A glucuronidation and the influence of alamethicin on in vitro kinetic measurements. Drug Metab Dispos 38:2232–2238
Meintieres S, Biola A, Pallardy M, Marzin D (2001) Apoptosis can be a confusing factor in in vitro clastogenic assays. Mutagenesis 16:243–250
Michaelis M, Selt F, Rothweiler F, Loschmann N, Nusse B, Dirks WG, Zehner R, Cinatl J Jr (2014) Aurora kinases as targets in drug-resistant neuroblastoma cells. PLoS ONE 9:e108758
Moore MM, Honma M, Clements J, Awogi T, Douglas GR, van Goethem F, Gollapudi B, Kimura A, Muster W, O’Donovan M, Schoeny R, Wakuri S (2011) Suitable top concentration for tests with mammalian cells: mouse lymphoma assay workgroup. Mutat Res 723:84–86
Muehlbauer PA, Schuler MJ (2005) Detection of numerical chromosomal aberrations by flow cytometry: a novel process for identifying aneugenic agents. Mutat Res 585:156–169
Nikolova T, Dvorak M, Jung F, Adam I, Kramer E, Gerhold-Ay A, Kaina B (2014) The gammaH2AX assay for genotoxic and nongenotoxic agents: comparison of H2AX phosphorylation with cell death response. Toxicol Sci 140:103–117
Orth JD, Loewer A, Lahav G, Mitchison TJ (2012) Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 induction. Mol Biol Cell 23:567–576
Parry JM, Fielder RJ, McDonald A (1994) Thresholds for aneuploidy-inducing chemicals. Advisory Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment of the UK Department of Health. Mutagenesis 9:503–504
Peng C, Arthur D, Liu F, Lee J, Xia Q, Lavin MF, Ng JC (2013) Genotoxicity of hydroquinone in A549 cells. Cell Biol Toxicol 29:213–227
Perrone CE, Takahashi KC, Williams GM (2002) Inhibition of human topoisomerase IIalpha by fluoroquinolones and ultraviolet A irradiation. Toxicol Sci 69:16–22
Prigent C, Dimitrov S (2003) Phosphorylation of serine 10 in histone H3, What for? J Cell Sci 116:3677–3685
Rakitsky VN, Koblyakov VA, Turusov VS (2000) Nongenotoxic (epigenetic) carcinogens: pesticides as an example. A critical review. Teratog Carcinog Mutagen 20:229–240
Sharma AK, Bhattacharya S, Khan SA, Khade B, Gupta S (2015) Dynamic alteration in H3 serine 10 phosphorylation is G1-phase specific during ionization radiation induced DNA damage response inhuman cells. Mutat Res 773:83–91
Singh AC, Kumar M, Jha AM (2003) Genotoxicity of lomefloxacin–an antibacterial drug in somatic and germ cells of Swiss albino mice in vivo. Mutat Res 535:35–42
Smart DJ, Ahmedi KP, Harvey JS, Lynch AM (2011) Genotoxicity screening via the gammaH2AX by flow assay. Mutat Res 715:25–31
Snyder RD, Cooper CS (1999) Photogenotoxicity of fluoroquinolones in Chinese hamster V79 cells: dependency on active topoisomerase II. Photochem Photobiol 69:288–293
Souid-Mensi G, Moukha S, Mobio TA, Maaroufi K, Creppy EE (2008) The cytotoxicity and genotoxicity of okadaic acid are cell-line dependent. Toxicon 51:1338–1344
Stopper H, Schmitt E, Kobras K (2005) Genotoxicity of phytoestrogens. Mutat Res 574:139–155
Tsamou M, Jennen DG, Claessen SM, Magkoufopoulou C, Kleinjans JC, van Delft JH (2012) Performance of in vitro gammaH2AX assay in HepG2 cells to predict in vivo genotoxicity. Mutagenesis 27:645–652
Valdiglesias V, Mendez J, Pasaro E, Cemeli E, Anderson D, Laffon B (2010) Assessment of okadaic acid effects on cytotoxicity, DNA damage and DNA repair in human cells. Mutat Res 689:74–79
Valdiglesias V, Prego-Faraldo MV, Pasaro E, Mendez J, Laffon B (2013) Okadaic acid: more than a diarrheic toxin. Mar Drugs 11:4328–4349
Vinken M, Doktorova T, Ellinger-Ziegelbauer H, Ahr HJ, Lock E, Carmichael P, Roggen E, van Delft J, Kleinjans J, Castell J, Bort R, Donato T, Ryan M, Corvi R, Keun H, Ebbels T, Athersuch T, Sansone SA, Rocca-Serra P, Stierum R, Jennings P, Pfaller W, Gmuender H, Vanhaecke T, Rogiers V (2008) The carcinoGENOMICS project: critical selection of model compounds for the development of omics-based in vitro carcinogenicity screening assays. Mutat Res 659:202–210
Watters GP, Smart DJ, Harvey JS, Austin CA (2009) H2AX phosphorylation as a genotoxicity endpoint. Mutat Res 679:50–58
Williams GM, Brunnemann KD, Smart DJ, Molina D, Jeffrey AM, Duan JD, Krebsfaenger N, Kampkoetter A, Schmuck G (2013) Relationship of cellular topoisomerase IIalpha inhibition to cytotoxicity and published genotoxicity of fluoroquinolone antibiotics in V79 cells. Chem Biol Interact 203:386–390
Wojcik K, Zarebski M, Cossarizza A, Dobrucki JW (2013) Daunomycin, an antitumor DNA intercalator, influences histone-DNA interactions. Cancer Biol Ther 14:823–832
Yoshida I, Ibuki Y (2014) Formaldehyde-induced histone H3 phosphorylation via JNK and the expression of proto-oncogenes. Mutat Res 770:9–18
Zacharaki P, Stephanou G, Demopoulos NA (2013) Comparison of the aneugenic properties of nocodazole, paclitaxel and griseofulvin in vitro. Centrosome defects and alterations in protein expression profiles. J Appl Toxicol 33:869–879
Acknowledgments
This work benefited from fruitful discussions with many genotoxicity experts who generously shared their experience, special thanks to Drs. David Kirkland, Richard Walmsley, Steven Bryce and Stephen Dertinger.
Funding
This work was supported in part by the French ANSES MYCO-TOX EST-13-214 and ANR “Contreperf” Grants.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Khoury, L., Zalko, D. & Audebert, M. Complementarity of phosphorylated histones H2AX and H3 quantification in different cell lines for genotoxicity screening. Arch Toxicol 90, 1983–1995 (2016). https://doi.org/10.1007/s00204-015-1599-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-015-1599-1